# BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease

> **NCT05399745** · — · RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 100 (estimated)

## Conditions studied

- Biliary Atresia
- Cognitive Impairment

## Interventions

- **OTHER:** Neurocognitive monitoring

## Key facts

- **NCT ID:** NCT05399745
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-01
- **Primary completion:** 2039-12-31
- **Final completion:** 2040-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05399745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05399745, "BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05399745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*